Contributing Factors to Physical Symptoms in Terminally-Ill Cancer Patients
نویسندگان
چکیده
منابع مشابه
Dyspnea in terminally ill cancer patients.
To determine the epidemiology of dyspnea in terminal cancer patients, we examined data from the National Hospice Study, which followed up patients during their last six weeks of life. The incidence of dyspnea in these patients was 70.2 percent, with prevalence rates generally exceeding 50 percent at any of three measurements. In addition to lung or pleural involvement by the tumor, the presence...
متن کاملSystematic review of hypnotherapy for treating symptoms in terminally ill adult cancer patients.
The aim of this review was to find the evidence for or against the use of hypnotherapy in the treatment of symptoms in terminally ill adult cancer patients. The title and abstract were evaluated following a search through Index Medicus/MEDLINE, EMBASE, CINHAHL, CancerLit, AHMED, Psychinfo, CISCOM, Cochrane and DARE. Search terms included hypnotherapy, cancer, terminal care and palliative care. ...
متن کاملAssociation between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies.
BACKGROUND To explore the association between hydration volume and symptoms during the last 3 weeks of life in terminally ill cancer patients. PATIENTS AND METHODS This was a multicenter, prospective, observational study of 226 consecutive terminally ill patients with abdominal malignancies. Primary responsible physicians and nurses evaluated the severity of membranous dehydration (dehydratio...
متن کاملSuicidality in terminally ill Japanese patients with cancer.
BACKGROUND The risk of suicide is higher in patients with cancer than in the general population, making end-of-life care of suicidal terminal patients with cancer critical. To identify factors and longitudinal changes associated with suicidality among terminally ill Japanese patients with cancer, a prospective cohort study was performed. METHODS Consecutive outpatients with cancer who registe...
متن کاملOral and dental disease in terminally ill cancer patients.
This study was supported in part by a centre grant from the National Health and Medical Research Council of Australia and a grant from Sandoz Pharma, Basle, Switzerland. 1 Ho KY, Weissberger AJ, Marbach P, Lazarus L. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly: effects of dose and frequency and long term safety. Ann Intern Med 1990;112:173-81. 2 Sassol...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pain and Symptom Management
سال: 1999
ISSN: 0885-3924
DOI: 10.1016/s0885-3924(99)00096-2